(Q80587772)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

main subject

hepatocellular carcinoma

1 reference

1 reference

1 reference

1 reference

Akiko Makiyama

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Yoshito Itoh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Akinori Kasahara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Yasuharu Imai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Sumio Kawata

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Kentaro Yoshioka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Hirohito Tsubouchi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Kendo Kiyosawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Shinichi Kakumu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Kiwamu Okita

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Norio Hayashi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Takeshi Okanoue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

number of pages

7

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1616-1622

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Which patients with hepatitis C develop liver complications?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Clinical characteristics of patients with chronic hepatitis C showing biochemical remission, without hepatitis C virus eradication, as a result of interferon therapy. The Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Transient biochemical response in interferon therapy decreases the development of hepatocellular carcinoma for five years and improves the long-term survival of chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Case report: Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Development of multicentric hepatocellular carcinoma after completion of interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Development of small hepatocellular carcinoma 80 months after clearance of hepatitis C virus with interferon therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Detection of hepatocellular carcinoma after interferon therapy for chronic hepatitis C: clinical study of 26 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alfa treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Analysis of hepatocellular carcinoma tumor growth detected in sustained responders to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Hepatocellular carcinoma in sustained responders of interferon-treated chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20537

7 January 2021

Identifiers

DOI

10.1002/CNCR.20537

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference